Ketorolac and Orphenadrine, aspirin, and caffeine interaction

Ketorolac and Orphenadrine, aspirin, and caffeine: both prescribing labels flag this combination with the strongest language, such as a contraindication, a boxed warning, or an instruction to avoid it.

Major

Do not combine without a prescriber's guidance. The label language below is the strongest FDA uses.

What the FDA labels say

From the Ketorolac (Ketorolac Tromethamine) label · effective 2024-12-31

Major

CONCOMITANT USE WITH NSAIDs Ketorolac tromethamine is CONTRAINDICATED in patients currently receiving aspirin or NSAIDs because of the cumulative risk of inducing serious NSAID-related side effects.

Boxed warningnames Orphenadrine, aspirin, and caffeineView label on DailyMed
Major

Ketorolac tromethamine should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs.

Contraindicationsnames Orphenadrine, aspirin, and caffeineView label on DailyMed
Major

Ketorolac tromethamine is contraindicated in patients currently receiving aspirin or NSAIDs because of the cumulative risks of inducing serious NSAID-related adverse events.

Contraindicationsnames Orphenadrine, aspirin, and caffeineView label on DailyMed
Major

This symptom complex typically occurs in asthmatic patients who experience rhinitis with or without nasal polyps, or who exhibit severe, potentially fatal bronchospasm after taking aspirin or other NSAIDs (see CONTRAINDICATIONS and PRECAUTIONS, PREEXISTING ASTHMA).

Warnings and precautionsnames Orphenadrine, aspirin, and caffeineView label on DailyMed
Major

The use of aspirin in patients with aspirin- sensitive asthma has been associated with severe bronchospasm which can be fatal.

Warnings and precautionsnames Orphenadrine, aspirin, and caffeineView label on DailyMed

From the Orphenadrine, aspirin, and caffeine (Norgesic) label · effective 2026-01-08

Major

Pregnancy Embryo-Fetal Toxicity Inform pregnant women to avoid use of aspirin and other NSAIDs starting at 30 weeks gestation because of the risk of the premature closing of the fetal ductus arteriosus.

Precautionsby drug classView label on DailyMed
Moderate

Data from observational studies regarding other potential embryofetal risks of NSAID use in women in the first or second trimesters of pregnancy are inconclusive.

Warningsby drug classView label on DailyMed

Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.

Open in the checker

Not medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.